About Invengene Private Limited
Data last updated: 10 January 2026
Invengene Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Inventia Healthcare Limited. It specialises in preventive health supplements, a part of the broader healthcare sector. Incorporated on 02 August 2023.
Registered with ROC Mumbai under CIN U21002MH2023PTC407959.
Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.51 Cr. It is led by directors including Janak Ramanlal Shah and Maya Janak Shah.
Last AGM: 30 August 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.75 Cr.
The company has a workforce of approximately 35 employees as per the latest available data. It operates as a subsidiary of Inventia Healthcare Limited.
The company is associated with 1 brand - Invengene. As per MCA filings, the company has open charges of ₹25 Cr on record.
For more details, the company can be reached via its website invengene.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressUnit No. 704 7Th Floor Solaris One Premises Co – Operative Society Limited, N. S. Phadke Marg, Mumbai, Maharashtra, India – 400069
-
IndustryHealthcare, Preventive Health Supplements
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Invengene Private Limited
Invengene Private Limited has one previous CIN (Corporate Identification Number): U21002MH2023PLC407959. The current CIN is U21002MH2023PTC407959, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21002MH2023PTC407959 | Current |
| U21002MH2023PLC407959 | Previous |
Associated Brands with Invengene Private Limited
Invengene Private Limited operates one associated brand: Invengene. These brands represent Invengene Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides R&D, manufacturing, and commercialization services for pharmaceuticals worldwide. | invengene.com |
Competitors & Alternatives of Invengene Private Limited
Brands and companies operating in the same space as Invengene Private Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
WuXi AppTec
|
Provider of CRO and CDMO services | Shanghai, China, China | 2000 |
ANI Pharmaceuticals
|
Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States, United States | 1996 |
Aptar
|
Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States, United States | 1992 |
CHEPLAPHARM
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
Red Nucleus
|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States, United States | 2014 |
Ipsen
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 1929 |
Eurofins Scientific
|
Laboratory testing and contract research services are provided globally. | Luxembourg, Luxembourg, Luxembourg | 1987 |
China Medical System
|
Generic formulations including tablets, capsules, liquids, and injectables are manufactured. | Shenzhen, China, China | 1992 |
Aliada Therapeutics
|
Provider of drug research & development services for multiple therapeutic areas | Boston, United States, United States | 2021 |
Auditor Details of Invengene Private Limited
Invengene Private Limited is audited by M S K C & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S K C & Associates | Locked | Locked | Locked |
Complete auditor history for Invengene Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Invengene Private Limited
Invengene Private Limited is currently managed by 6 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Janak Ramanlal Shah
Also directs:
Invengene Private Limited
|
Individual Subscriber | 02 Aug 2023 | 2 Years 11 Months | Current |
|
Maya Janak Shah
Also directs:
Invengene Private Limited, Emjay Ventures Llp
|
Individual Subscriber | 02 Aug 2023 | 2 Years 11 Months | Current |
| Rajat Vishal Shah | Individual Subscriber | 02 Aug 2023 | 2 Years 11 Months | Current |
| Ankur Janak Shah | Whole-Time Director | 02 Aug 2023 | 2 Years 11 Months | Current |
| Vishal Janak Shah | Individual Subscriber | 02 Aug 2023 | 2 Years 11 Months | Current |
|
Vaibhavi Ankur Shah
Also directs:
Invengene Private Limited, Va3 Ventures Llp, Tpc Enterprise Private Limited and 1 more
|
Whole-Time Director | 02 Aug 2023 | 2 Years 11 Months | Current |
Financials of Invengene Private Limited FY 2025 filings available
Invengene Private Limited reported revenue of ₹11.75 Cr for FY 2025.
Ten-year financial statements for Invengene Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Invengene Private Limited
Shareholding and ownership data for Invengene Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Invengene Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2025 | Others | ₹25 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Invengene Private Limited
View historical data on people associated with Invengene Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Invengene Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Invengene Private Limited
GST registrations and filing compliance for Invengene Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Invengene Private Limited
Credit ratings, litigation, and regulatory alerts for Invengene Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Invengene Private Limited
MSME payment history for Invengene Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Invengene Private Limited
Corporate group structure for Invengene Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Invengene Private Limited
MCA filings and documents for Invengene Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Invengene Private Limited
Frequently Asked Questions about Invengene Private Limited
Invengene Private Limited is an active private limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 02 August 2023 (3+ years old) and is registered under CIN U21002MH2023PTC407959. The company has 35 employees.
Invengene Private Limited reported revenue of ₹11.75 Cr for FY 2025.
The current directors of Invengene Private Limited are:
- Janak Ramanlal Shah - Individual Subscriber
- Maya Janak Shah - Individual Subscriber
- Rajat Vishal Shah - Individual Subscriber
- Ankur Janak Shah - Whole-Time Director
- Vishal Janak Shah - Individual Subscriber
- Vaibhavi Ankur Shah - Whole-Time Director
The primary industry of Invengene Private Limited is healthcare. The company specifically operates in preventive health supplements. The company is currently active in this sector.
Invengene Private Limited can be reached at the registered office: Unit No. 704 7Th Floor Solaris One Premises Co – Operative Society Limited, N. S. Phadke Marg, Mumbai, Maharashtra, India – 400069, or through the website invengene.com.
The authorised capital is ₹3 Cr, and the paid-up capital is ₹1.51 Cr.